scispace - formally typeset
N

Nan Lin

Researcher at Harvard University

Publications -  1220
Citations -  65601

Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.

Papers
More filters
Journal ArticleDOI

Survival in Patients with Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

TL;DR: The updated Graded Prognostic Assessment (GPA) provides an accurate tool with which to estimate survival, individualize treatment, and stratify clinical trials and is recommended for expansion of eligibility to allow for the enrollment of patients with previously treated brain metastases.
Book ChapterDOI

The Position Generator: Measurement Techniques for Investigations of Social Capital

TL;DR: This paper argued that the scientific viability of the notion of social capital depends on the development of an approach that integrates theory and measurement of the concept and illustrated the utility of the position-generator methodology with data from an island-wide survey of employed labor forces in Taiwan.
Journal ArticleDOI

A cross-cultural comparison of depressive symptom manifestation: China and the United States.

TL;DR: The findings seem to suggest that the tendency toward somatic symptom reporting is not any greater among Chinese populations but may be a function of having a mental illness or of help seeking in China.
Journal Article

Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.

TL;DR: It is argued that the hematopoietic progenitor cell compartment responds to Tpo as a whole and that the in vivo effects of Tpo administration may be more wide-ranging than previously anticipated.